Shopping Cart
- Remove All
- Your shopping cart is currently empty
SQ-31765 is a blocker of benzazepine calcium channel.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.586 € | 6-8 weeks | |
50 mg | 2.071 € | 6-8 weeks | |
100 mg | 2.660 € | 6-8 weeks |
Description | SQ-31765 is a blocker of benzazepine calcium channel. |
In vivo | SQ-31765 (SQ 31,765) effectively mitigates ischemia severity independent of myocardial blood flow or hemodynamic changes. In a study, anesthetized dogs were administered saline (n=6), SQ-31765 (n=6; 0.2 mg/kg), or SQ 32,189 (n=6; 0.2 mg/kg) intravenously 10 minutes before inducing ischemia. The study examined the compound's impact on pacing-induced ST-segment elevation and myocardial blood flow during left anterior descending coronary artery stenosis. SQ-31765 significantly reduced ST-segment elevation (P<0.05) at 10, 40, and 70 minutes post-infusion, showing a notable reduction (5.9±1.4 mV at 70 minutes) compared to the saline group (12.0±1.4 mV at 70 minutes). All test groups exhibited decreased subendocardial flow due to left anterior descending coronary artery stenosis during atrial pacing before drug administration, highlighting SQ-31765's protective effects against pacing-induced myocardial injury. |
Molecular Weight | 464.48 |
Formula | C24H27F3N2O4 |
Cas No. | 138383-07-0 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.